| Real-world outcomes and management strategies for venetoclax-treated chronic lymphocytic leukemia patients in the United States AR Mato, M Thompson, JN Allan, DM Brander, JM Pagel, CS Ujjani, ... Haematologica 103 (9), 1511, 2018 | 168 | 2018 |
| Longitudinal trajectory and characterization of cancer-related cognitive impairment in a nationwide cohort study MC Janelsins, CE Heckler, LJ Peppone, TA Ahles, SG Mohile, ... Journal of Clinical Oncology 36 (32), 3231, 2018 | 130 | 2018 |
| Cumulative burden of morbidity among testicular cancer survivors after standard cisplatin-based chemotherapy: a multi-institutional study SL Kerns, C Fung, PO Monahan, S Ardeshir-Rouhani-Fard, MIA Zaid, ... Journal of Clinical Oncology 36 (15), 1505, 2018 | 122 | 2018 |
| Multi-institutional assessment of adverse health outcomes among North American testicular cancer survivors after modern cisplatin-based chemotherapy C Fung, HD Sesso, AM Williams, SL Kerns, P Monahan, MA Zaid, ... Journal of Clinical Oncology 35 (11), 1211, 2017 | 107 | 2017 |
| Associations between inflammatory markers and cognitive function in breast cancer patients receiving chemotherapy ALM Williams, R Shah, M Shayne, AJ Huston, M Krebs, N Murray, ... Journal of neuroimmunology 314, 17-23, 2018 | 91 | 2018 |
| What is known and unknown about chemotherapy‐related cognitive impairment in patients with haematological malignancies and areas of needed research AM Williams, CS Zent, MC Janelsins British journal of haematology 174 (6), 835-846, 2016 | 80 | 2016 |
| Tumor lysis, adverse events, and dose adjustments in 297 venetoclax-treated CLL patients in routine clinical practice LE Roeker, CP Fox, TA Eyre, DM Brander, JN Allan, SJ Schuster, ... Clinical Cancer Research 25 (14), 4264-4270, 2019 | 78 | 2019 |
| Analysis of the risk of infection in patients with chronic lymphocytic leukemia in the era of novel therapies ALM Williams, AM Baran, PJ Meacham, MM Feldman, HE Valencia, ... Leukemia & Lymphoma 59 (3), 625-632, 2018 | 77 | 2018 |
| Long-term morbidity of testicular cancer treatment C Fung, SD Fossa, A Williams, LB Travis Urologic Clinics 42 (3), 393-408, 2015 | 73 | 2015 |
| Association between metabolic syndrome and periodontal disease measures in postmenopausal women: the Buffalo OsteoPerio study MJ LaMonte, ALM Williams, RJ Genco, CA Andrews, KM Hovey, ... Journal of periodontology 85 (11), 1489-1501, 2014 | 58 | 2014 |
| Fatigue, anxiety, and quality of life in breast cancer patients compared to non-cancer controls: a nationwide longitudinal analysis ALM Williams, CP Khan, CE Heckler, DL Barton, M Ontko, J Geer, ... Breast Cancer Research and Treatment 187 (1), 275-285, 2021 | 55 | 2021 |
| Rethinking success in pediatric oncology: beyond 5-year survival ALM Williams, Q Liu, N Bhakta, KR Krull, MM Hudson, LL Robison, ... Journal of Clinical Oncology 39 (20), 2227-2231, 2021 | 43 | 2021 |
| Clinical and genetic risk factors for adverse metabolic outcomes in North American testicular cancer survivors MA Zaid, WG Gathirua-Mwangi, C Fung, PO Monahan, O El-Charif, ... Journal of the National Comprehensive Cancer Network 16 (3), 257-265, 2018 | 36 | 2018 |
| Childhood neurotoxicity and brain resilience to adverse events during adulthood ALM Williams, YT Cheung, G Hyun, W Liu, KK Ness, MJ Ehrhardt, ... Annals of Neurology 89 (3), 534-545, 2021 | 35 | 2021 |
| Predicting cardiovascular disease among testicular cancer survivors after modern cisplatin-based chemotherapy: application of the Framingham Risk Score DR Feldman, S Ardeshir-Rouhani-Fard, P Monahan, HD Sesso, C Fung, ... Clinical genitourinary cancer 16 (4), e761-e769, 2018 | 35 | 2018 |
| A retrospective comparison of venetoclax alone or in combination with an anti-CD20 monoclonal antibody in R/R CLL AR Mato, LE Roeker, TA Eyre, C Nabhan, N Lamanna, BT Hill, ... Blood advances 3 (10), 1568-1573, 2019 | 31 | 2019 |
| Ibrutinib dose adherence and therapeutic efficacy in non-hodgkin lymphoma: a single-center experience ALM Williams, AM Baran, C Casulo, P Reagan, JW Friedberg, M Helber, ... Clinical Lymphoma Myeloma and Leukemia 19 (1), 41-47, 2019 | 27 | 2019 |
| Physiologic frailty and neurocognitive decline among young-adult childhood cancer survivors: a prospective study from the St Jude Lifetime Cohort ALM Williams, KR Krull, CR Howell, P Banerjee, TM Brinkman, SC Kaste, ... Journal of Clinical Oncology 39 (31), 3485-3495, 2021 | 26 | 2021 |
| Management of melanoma in patients with chronic lymphocytic leukemia WJ Archibald, PJ Meacham, ALM Williams, AM Baran, AI Victor, PM Barr, ... Leukemia Research 71, 43-46, 2018 | 22 | 2018 |
| Cognitive function in cancer survivors: analysis of the 1999–2002 National Health and Nutrition Examination Survey AM Williams, MC Janelsins, E van Wijngaarden Supportive Care in Cancer 24 (5), 2155-2162, 2016 | 20 | 2016 |
